Literature DB >> 15939234

Cell culture models of the ocular barriers.

Margit Hornof1, Elisa Toropainen, Arto Urtti.   

Abstract

The presence of tight barriers, which regulate the environment of ocular tissues in the anterior and posterior part of the eye, is essential for normal visual function. The development of strategies to overcome these barriers for the targeted ocular delivery of drugs, e.g. to the retina, remains a major challenge. During the last years numerous cell culture models of the ocular barriers (cornea, conjunctiva, blood-retinal barrier) have been established. They are considered to be promising tools for studying the drug transport into ocular tissues, and for numerous other purposes, such as the investigation of pathological ocular conditions, and the toxicological screening of compounds as alternative to in vivo toxicity tests. The further development of these in vitro models will require more detailed investigations of the barrier properties of both the cell culture models and the in vivo ocular barriers. It is the aim of this review to describe the current status in the development of cell culture models of the ocular barriers, and to discuss the applicability of these models in pharmaceutical research.

Entities:  

Mesh:

Year:  2005        PMID: 15939234     DOI: 10.1016/j.ejpb.2005.01.009

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  45 in total

1.  Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness.

Authors:  A Sood; S Salih; D Roh; L Lacharme-Lora; M Parry; B Hardiman; R Keehan; R Grummer; E Winterhager; P J Gokhale; P W Andrews; C Abbott; K Forbes; M Westwood; J D Aplin; E Ingham; I Papageorgiou; M Berry; J Liu; A D Dick; R J Garland; N Williams; R Singh; A K Simon; M Lewis; J Ham; L Roger; D M Baird; L A Crompton; M A Caldwell; H Swalwell; M Birch-Machin; G Lopez-Castejon; A Randall; H Lin; M-S Suleiman; W H Evans; R Newson; C P Case
Journal:  Nat Nanotechnol       Date:  2011-11-06       Impact factor: 39.213

2.  General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.

Authors:  Feng Deng; Veli-Pekka Ranta; Heidi Kidron; Arto Urtti
Journal:  Pharm Res       Date:  2016-07-18       Impact factor: 4.200

Review 3.  In vitro reconstructed 3D corneal tissue models for ocular toxicology and ophthalmic drug development.

Authors:  Yulia Kaluzhny; Mitchell Klausner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-02-05       Impact factor: 2.416

Review 4.  Novel strategies for anterior segment ocular drug delivery.

Authors:  Kishore Cholkar; Sulabh P Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-05       Impact factor: 2.671

5.  Retina-choroid-sclera permeability for ophthalmic drugs in the vitreous to blood direction: quantitative assessment.

Authors:  Nahid Haghjou; Mohammad J Abdekhodaie; Yu-Ling Cheng
Journal:  Pharm Res       Date:  2012-10-02       Impact factor: 4.200

6.  Planar microdevices enhance transport of large molecular weight molecules across retinal pigment epithelial cells.

Authors:  Jennifer S Wade; Tejal A Desai
Journal:  Biomed Microdevices       Date:  2014-08       Impact factor: 2.838

7.  Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin.

Authors:  J R Costa; N C Silva; B Sarmento; M Pintado
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-03-10       Impact factor: 3.267

8.  Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.

Authors:  Kishore Cholkar; Ashaben Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Recent Pat Nanomed       Date:  2012

9.  mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs.

Authors:  Christian Kölln; Stephan Reichl
Journal:  J Ocul Pharmacol Ther       Date:  2011-12-23       Impact factor: 2.671

10.  Gene expression analysis in SV-40 immortalized human corneal epithelial cells cultured with an air-liquid interface.

Authors:  Dario Greco; Kati-Sisko Vellonen; Helen C Turner; Marika Häkli; Timo Tervo; Petri Auvinen; J Mario Wolosin; Arto Urtti
Journal:  Mol Vis       Date:  2010-10-15       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.